Evotec SE Stock Deutsche Boerse AG
Stocks
EVT
DE0005664809
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Tradegate
07:53:00 07/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 2.915 EUR | -6.15% |
|
-5.54% | -45.71% |
| 06/10 | Investors seek stocks in diagnostics and laboratory sector | DP |
| 06/10 | Frankfurt Stocks Open Higher: Dax Rises After Positive Signals From US | DP |
| Market Cap | 522M 588M 489M 443M 837M 56.71B 843M 5.87B 2.28B 28.93B 2.21B 2.16B 93B | P/E 2026 * |
-2.3x | P/E 2027 * | -6.83x |
|---|---|---|---|---|---|
| Enterprise Value | 665M 749M 622M 564M 1.07B 72.22B 1.07B 7.48B 2.91B 36.84B 2.81B 2.75B 118B | EV / Sales 2026 * |
1.11x | EV / Sales 2027 * | 0.95x |
| Free-Float |
89.91% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| EVT | Delayed | |
CBOE
| EVTd | Real-time | |
|
Tradegate
| EVT | Real-time | |
|
Boerse Muenchen
| EVT | Real-time | |
|
Börse Stuttgart
| EVT | Delayed | |
|
Deutsche Boerse AG
| EVT | Delayed | |
|
Bulgaria S.E.
| EVT | End-of-day quote | |
|
OTC Markets
| EVOTF | Delayed | |
|
Borsa Italiana
| 1EVT | End-of-day quote | |
|
Wiener Boerse
| EVT | End-of-day quote | |
|
London S.E.
| 0IRF | Delayed | |
|
CBOE
| 0IRF | Real-time | |
|
Swiss Exchange
| EVT | Delayed |
Last Transcript: Evotec SE
| 1 day | -6.15% | ||
| 1 week | -5.54% | ||
| Current month | -5.54% | ||
| 1 month | -6.73% | ||
| 3 months | -42.33% | ||
| 6 months | -33.87% | ||
| Current year | -45.71% |
| 1 week | 2.9 |  | 3.11 |
| 1 month | 2.73 | | 3.19 |
| Current year | 2.73 | | 6.66 |
| 1 year | 2.73 | | 7.49 |
| 3 years | 2.73 | | 21.7 |
| 5 years | 2.73 | | 45.43 |
| 10 years | 2.73 | | 45.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 01/07/2024 | |
| Director of Finance/CFO | - | 01/05/2026 | |
Ingrid Müller
COO | Chief Operating Officer | - | 01/05/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Roland Sackers
BRD | Director/Board Member | 58 | 19/06/2019 |
| Director/Board Member | 64 | 01/06/2021 | |
Duncan McHale
BRD | Director/Board Member | 59 | 10/06/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.15% | -5.54% | - | - | 588M | |
| +4.16% | +4.16% | +49.37% | +94.17% | 74.69B | |
| -1.13% | -2.53% | +21.56% | +76.75% | 58.81B | |
| +0.21% | +0.24% | +6.74% | +34.41% | 48.45B | |
| -3.76% | -2.25% | +329.09% | +698.20% | 42.84B | |
| -2.30% | -3.35% | +26.81% | +30.88% | 42.79B | |
| +0.31% | -0.68% | +5.30% | +108.64% | 41.25B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.13B | |
| -2.07% | +1.16% | +35.00% | +26.28% | 30.28B | |
| -1.96% | -2.88% | -8.97% | -13.92% | 24.05B | |
| Average | -1.29% | -0.25% | +52.68% | +123.12% | 43.81B | |
| Weighted average by Cap. | -0.28% | -0.54% | +55.48% | +129.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 601M 677M 562M 510M 963M 65.25B 970M 6.75B 2.63B 33.29B 2.54B 2.49B 107B | 724M 816M 678M 614M 1.16B 78.63B 1.17B 8.14B 3.17B 40.11B 3.06B 3B 129B |
| Net income | -222M -250M -208M -188M -356M -24.11B -358M -2.5B -970M -12.3B -939M -919M -39.54B | -48.25M -54.35M -45.15M -40.93M -77.29M -5.24B -77.85M -542M -211M -2.67B -204M -200M -8.59B |
| Net Debt | 143M 161M 134M 121M 229M 15.51B 230M 1.61B 624M 7.91B 604M 591M 25.44B | 162M 183M 152M 138M 260M 17.61B 262M 1.82B 709M 8.98B 686M 671M 28.88B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/10/26 | EUR 2.964 | -4.57% | 1,400 |
| 06/10/26 | EUR 3.106 | +5.72% | 2,640 |
| 05/10/26 | EUR 2.938 | +0.41% | 3,120 |
| 02/10/26 | EUR 2.926 | -5.12% | 1,550 |
| 01/10/26 | EUR 3.084 | -1.72% | 8,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EVT Stock
- EVT Stock
Select your edition
All financial news and data tailored to specific country editions
